Kaupinen Wes 13D and 13G filings for Palvella Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-20 5:32 pm Purchase |
2024-12-13 | 13D | Palvella Therapeutics, Inc. PVLA |
Kaupinen Wes | 1,644,869 14.600% |
1,644,869 (New Position) |
Filing |